BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Velcera Licenses New Pet Medicine


6/4/2009 11:35:38 AM

YARDLEY, PA--(Marketwire - June 03, 2009) - Velcera, Inc., a specialty pharmaceutical company focused on pet health, announced that it entered into a global licensing agreement with a multinational animal health company. The global agreement calls for the licensing partner to develop, register and commercialize a novel pet medicine utilizing Velcera's patented oral mucosal drug delivery technology branded Promist™. While the terms of the agreement are confidential, it calls for upfront payments, developmental milestone payments, as well as royalties based upon sales.

"We are very pleased to enter into this license and development agreement for an important pet medicine that will improve the ease of administration for pets and owners," said Dennis Steadman, CEO of Velcera. "This agreement will help pet owners access our technology to improve pet health. We look forward to a long-term relationship and additional products in the future," Steadman added.

About Velcera

Velcera (www.velcera.com) is a specialty pharmaceutical company focused on innovation in the expanding pet health market. Velcera's product development targets pet medicines that can provide superior convenience, value and compliance. Product candidates based upon the patented Promist™ delivery technology have the potential to improve pet health as pet parents avoid the challenges of getting pets to swallow pills.


Velcera, Inc. Contact:
Dennis F. Steadman
(267)-757-3600



Read at BioSpace.com

Velcera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES